Live from the NIH registry
Studies recruiting near El Paso right now
Top 25 of 188 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50781 — El Paso, Texas (7.0 mi)
· Sponsor: UCB Biopharma SRL
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Davita Clinical Research — El Paso, Texas (7.0 mi)
· Sponsor: Novo Nordisk A/S
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
El Paso Pulmonary Association — El Paso, Texas (7.0 mi)
· Sponsor: Philip Morris Products S.A.
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Asthma
N/A
Observational 2,500 participants sought
El Paso Pulmonary Association (EPPA) - West El Paso - Site Number: 840108 — El Paso, Texas (7.0 mi)
· Sponsor: Sanofi
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Renovatio Clinical - El Paso — El Paso, Texas (7.0 mi)
· Sponsor: Hoffmann-La Roche
Pelacarsen Roll-over Extension Program
Atherosclerotic Cardiovascular Disease
Phase 3
Interventional 599 participants sought
David Turbay MD PLLC — El Paso, Texas (7.0 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: PedAL BCU, LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Academy of Diabetes, Thyroid and Endocrine /ID# 255735 — El Paso, Texas (7.0 mi)
· Sponsor: AbbVie
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Pulmonary Hypertension Associated With HFpEF
Phase 3
Interventional 540 participants sought
Tenax Investigational Site — El Paso, Texas (7.0 mi)
· Sponsor: Tenax Therapeutics, Inc.
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
El Paso Cardiovascular Care — El Paso, Texas (7.0 mi)
· Sponsor: Baylor Research Institute
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
3A Research Llc West Location — El Paso, Texas (7.0 mi)
· Sponsor: Incyte Corporation
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
Alagille Syndrome
N/A
Observational 30 participants sought
Proactive El Paso,LLC — El Paso, Texas (7.0 mi)
· Sponsor: Ipsen
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Nephritis, Lupus, Lupus Erythematosus, Systemic
Phase 3
Interventional 300 participants sought
Texas Arthritis Center — El Paso, Texas (7.0 mi)
· Sponsor: Viatris Innovation GmbH
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — El Paso, Texas (7.0 mi)
· Sponsor: AstraZeneca
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Hypertriglyceridemia
Phase 3
Interventional 869 participants sought
Research Site 27 — El Paso, Texas (7.0 mi)
· Sponsor: Arrowhead Pharmaceuticals
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
David Turbay, MD — El Paso, Texas (7.0 mi)
· Sponsor: Amgen
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
3A Research - East El Paso /ID# 239193 — El Paso, Texas (7.0 mi)
· Sponsor: AbbVie
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 34 — El Paso, Texas (7.0 mi)
· Sponsor: Merus B.V.
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Agitation, Alzheimer Disease
Phase 2
Interventional 120 participants sought
ANESC Research — El Paso, Texas (7.0 mi)
· Sponsor: Celgene
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
Phase 1, Phase 2
Interventional 340 participants sought
Renovatio Clinical - El Paso — El Paso, Texas (7.0 mi)
· Sponsor: Inhibrx Biosciences, Inc
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 3,850 participants sought
Research Site — El Paso, Texas (7.0 mi)
· Sponsor: AstraZeneca
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
El Paso Eye Surgeons /ID# 268356 — El Paso, Texas (7.0 mi)
· Sponsor: AbbVie